The new beta-lactamase-stable cephalosporins.
D001424:Bacterial Infections / Q000188:drug therapy; D002493:Central Nervous System Diseases / Q000188:drug therapy; D002511:Cephalosporins / Q000008:administration & dosage / Q000009:adverse effects / Q000378:metabolism / Q000494:pharmacology* / Q000627:therapeutic use; D055598:Chemical Phenomena; D002621:Chemistry; D004697:Endocarditis, Bacterial / Q000188:drug therapy; D004755:Enterobacteriaceae / Q000187:drug effects; D011550:Pseudomonas aeruginosa / Q000187:drug effects; D012141:Respiratory Tract Infections / Q000188:drug therapy; D018805:Sepsis / Q000188:drug therapy; D013291:Streptococcus / Q000187:drug effects; D013530:Surgical Wound Infection / Q000188:drug therapy; D014552:Urinary Tract Infections / Q000188:drug therapy; D001618:beta-Lactamases / Q000378:metabolism*
D002511:Cephalosporins; D001618:beta-Lactamases